To further validate if EPHA2 was necessary for EFNA1 promoting ESCC progression, we examined the cell viability of ESCC cells with EPHA2 knockdown and found that decreased EPHA2 significantly inhibited cell proliferation (Fig. 5d, e). Here, EPHA2 is linked to esophageal squamous cell carcinoma.